Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

Why Is Verici Dx Down 8.89% Today? Investors Watch Kidney Transplant Diagnostics Growth

Verici Dx plc, LSE:VRCI, fell8.89% on 19 August 2026, extending the intenseVolatilitythat has characterised the company's share price during recent months.

Ankur Sharma | 19 August 2026

Why Is Proteome Sciences Down 7.64% Today? Investors Watch Chemoproteomics Growth

Proteome Sciences plc, LSE:PRM, fell7.64% on 19 August 2026, making it one of the more significant decliners among the smaller UK healthcare and life-science companies.

Ankur Sharma | 19 August 2026

LSE:THAT Falls Sharply as Investors Reassess Thalia Therapeutics’ Clinical-Stage Growth Story

Thalia Therapeutics plc, LSE:THAT, fell7.69% on 19 August 2026, making it one of the more notable declines among UK small-cap healthcare shares.

Ankur Sharma | 19 August 2026

Oxford Nanopore Technologies Stock Surges as Margin Recovery and Clinical Growth Revive Bullish Momentum

Oxford Nanopore Technologies rose by 7.21% as investors responded positively to evidence that management’s profitability strategy is gaining traction. The interim update showed continuedRevenueexpansion, material gross-margin improvement and a significant reduction in adjusted operating losses. These trends strengthened confidence in the company’s stated path …

Ankur Sharma | 19 August 2026

Eden Research LSE:EDEN Rises 6.65%: What Investors Are Watching After New Global Product Approvals?

Eden Research has moved firmly into focus after its shares gained6.65% on 19 August 2026.

Ankur Sharma | 19 August 2026

Why Faron Pharmaceuticals LSE:FARN Is Rising as Bexmarilimab and August Results Take Centre Stage?

Faron Pharmaceuticals has returned to the spotlight after its shares gained7.36% on 19 August 2026. The timing is particularly notable because the clinical-stage biotechnology company is approaching a potentially important disclosure date.

Ankur Sharma | 19 August 2026

LSE:IMM Share Price Rises 9.76%: Could P140 and Kapiglucagon Drive the Next Growth Phase?

ImmuPharma plc has attracted renewed investor attention on 19 August 2026 afterLSE:IMM climbed 9.76%.

Ankur Sharma | 19 August 2026

LSE:CRTX Share Price Rises 6.79%: What Is Driving Fresh Interest in CRISM Therapeutics?

CRISM Therapeutics has attracted renewed market attention after its shares gained6.79% on 19 August 2026.

Ankur Sharma | 19 August 2026

Is Hemogenyx Pharmaceuticals Becoming a High-Potential UK Biotech Stock to Watch in 2026?

Hemogenyx Pharmaceuticals PLC attracted renewed attention on18 August 2026 after LSE:HEMO climbed 5.26%.

Ankur Sharma | 19 August 2026

Why Is Ondine Biomedical Stock Up 7.44% as Investors Await Crucial Phase 3 Results?

Ondine Biomedical Inc. LSE:OBI gained7.44% on 18 August 2026, with investor attention increasingly focused on a potentially decisive period for the company's clinical and commercial strategy.

Ankur Sharma | 19 August 2026
Support

Hi! How can we help you today?

Loading…